Galecto Stock (NASDAQ: GLTO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 223.200K |
Day Range | - - - |
52 Wk Range | 0.500 - 3.700 |
Market Cap | $18.464M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 0.16% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Galecto (NASDAQ: GLTO) through any online brokerage.
Other companies in Galecto’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Addex Therapeutics (NASDAQ:ADXN).
The latest price target for Galecto (NASDAQ: GLTO) was reported by HC Wainwright & Co. on Thursday, September 28, 2023. The analyst firm set a price target for 0.00 expecting GLTO to fall to within 12 months (a possible -100.00% downside). 8 analyst firms have reported ratings in the last year.
The stock price for Galecto (NASDAQ: GLTO) is $0.681 last updated April 22, 2024 at 6:56 PM EDT.
There are no upcoming dividends for Galecto.
Galecto’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Galecto.
Galecto is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.